Orchard Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-90,733
Closed -$8.71M 58
2024
Q3
$8.71M Sell
90,733
-52,372
-37% -$4.71M 3% 17
2024
Q2
$12.3M Sell
143,105
-1,667
-1% -$140K 3.71% 7
2024
Q1
$12M Buy
144,772
+1,667
+1% +$122K 3.51% 7
2023
Q4
$9.55M Buy
143,105
+7,639
+6% +$495K 2.99% 16
2023
Q3
$9.1M Hold
135,466
3.36% 9
2023
Q2
$9.17M Hold
135,466
3.09% 13
2023
Q1
$7.33M Hold
135,466
2.45% 21
2022
Q4
$8.1M Hold
135,466
2.72% 15
2022
Q3
$6.13M Sell
135,466
-34,815
-20% -$1.74M 2.29% 23
2022
Q2
$6.88M Buy
170,281
+4,903
+3% +$252K 2.15% 26
2022
Q1
$9.36M Buy
165,378
+26,648
+19% +$1.39M 2.66% 17
2021
Q4
$7.2M Buy
138,730
+2,640
+2% +$136K 2.11% 22
2021
Q3
$8.12M Hold
136,090
2.44% 21
2021
Q2
$8.45M Buy
136,090
+4,622
+4% +$308K 2.44% 22
2021
Q1
$8.57M Buy
131,468
+13,006
+11% +$848K 2.69% 18
2020
Q4
$7.79M Buy
+118,462
New +$6.97M 3.32% 13

Other funds holding EHC

Orchard Capital Management's EHC Position: Q4 2024 in Review

Orchard Capital Management sold out of Encompass Health (EHC) in Q4 2024, closing a stake of 90,733 shares — an estimated $8.71M sold.

Orchard Capital Management first reported a position in EHC in Q4 2020 and held it in 16 quarters. The position peaked at $12.3M in Q2 2024. 544 funds tracked by Wall St. Rank hold EHC as of Q4 2024.

  • Orchard Capital Management reported no remaining Encompass Health position as of Q4 2024 after selling out during the quarter.
  • Orchard Capital Management sold 90,733 Encompass Health shares in Q4 2024, an estimated $8.71M.
  • Orchard Capital Management first reported a position in Encompass Health in Q4 2020 and held it in 16 quarters.
  • Orchard Capital Management's Encompass Health position peaked at $12.3M in Q2 2024.
  • 544 funds tracked by Wall St. Rank held Encompass Health as of Q4 2024.

Based on Orchard Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.